Pharming receives UK approval for Joenja in children aged 4 to 11 with APDS

Pharming received UK approval for Joenja in children aged 4 to 11 with APDS, supported by pediatric clinical program data. The approval marks a step in the company's expansion across age groups and markets.

Detected & updated continuously · Source: Nebula